Samsara BioCapital as of March 31, 2023
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 56 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chinook Therapeutics | 24.6 | $120M | 5.2M | 23.15 | |
| Mineralys Therapeutics (MLYS) | 14.6 | $71M | 4.5M | 15.66 | |
| Scholar Rock Hldg Corp (SRRK) | 7.6 | $37M | 4.6M | 8.00 | |
| Arcellx Common Stock (ACLX) | 5.8 | $28M | 910k | 30.81 | |
| Graphite Bio | 4.3 | $21M | 8.5M | 2.45 | |
| Rain Therapeutics | 4.1 | $20M | 2.3M | 8.74 | |
| Iveric Bio | 3.4 | $17M | 687k | 24.33 | |
| Zymeworks Del (ZYME) | 3.0 | $15M | 1.6M | 9.04 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.9 | $14M | 695k | 20.08 | |
| Avadel Pharmaceuticals Sponsored Adr | 2.7 | $13M | 1.4M | 9.16 | |
| Nkarta (NKTX) | 2.1 | $10M | 2.9M | 3.55 | |
| Hillevax (HLVX) | 2.1 | $10M | 610k | 16.53 | |
| Intercept Pharmaceuticals In | 1.8 | $8.6M | 641k | 13.43 | |
| Pepgen (PEPG) | 1.6 | $8.0M | 651k | 12.23 | |
| Sutro Biopharma (STRO) | 1.6 | $7.7M | 1.7M | 4.62 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.3 | $6.5M | 1.7M | 3.85 | |
| Rhythm Pharmaceuticals (RYTM) | 1.3 | $6.2M | 345k | 17.84 | |
| Dice Therapeutics | 1.2 | $5.8M | 203k | 28.65 | |
| Prime Medicine (PRME) | 1.2 | $5.8M | 470k | 12.30 | |
| Aclaris Therapeutics (ACRS) | 1.2 | $5.6M | 696k | 8.09 | |
| Amryt Pharma Sponsored Ads | 0.9 | $4.4M | 305k | 14.58 | |
| Janux Therapeutics (JANX) | 0.9 | $4.4M | 360k | 12.10 | |
| Immunocore Hldgs Ads (IMCR) | 0.8 | $4.0M | 81k | 49.44 | |
| Atyr Pharma Com New (ATYR) | 0.8 | $3.7M | 1.8M | 2.10 | |
| Lyra Therapeutics (LYRA) | 0.7 | $3.6M | 1.8M | 2.01 | |
| Immatics SHS (IMTX) | 0.7 | $3.4M | 495k | 6.90 | |
| Inozyme Pharma (INZY) | 0.6 | $2.9M | 504k | 5.73 | |
| Day One Biopharmaceuticals I (DAWN) | 0.5 | $2.6M | 196k | 13.37 | |
| Tango Therapeutics (TNGX) | 0.5 | $2.5M | 630k | 3.95 | |
| Decibel Therapeutics | 0.5 | $2.4M | 802k | 3.02 | |
| Terns Pharmaceuticals (TERN) | 0.5 | $2.4M | 202k | 11.84 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.5 | $2.4M | 882k | 2.67 | |
| Leap Therapeutics | 0.5 | $2.3M | 6.7M | 0.34 | |
| Igm Biosciences (IGMS) | 0.4 | $2.1M | 155k | 13.74 | |
| Io Biotech (IOBT) | 0.4 | $1.9M | 1.0M | 1.88 | |
| Elevation Oncology (ELEV) | 0.3 | $1.6M | 831k | 1.90 | |
| Bolt Biotherapeutics (BOLT) | 0.3 | $1.5M | 1.0M | 1.39 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.3 | $1.4M | 480k | 2.94 | |
| Vtv Therapeutics Cl A | 0.3 | $1.3M | 1.6M | 0.81 | |
| Alx Oncology Hldgs (ALXO) | 0.2 | $1.2M | 263k | 4.52 | |
| Instil Bio | 0.2 | $1.2M | 1.8M | 0.66 | |
| Viracta Therapeutics (VIRX) | 0.2 | $1.1M | 690k | 1.59 | |
| Allakos (ALLK) | 0.2 | $766k | 172k | 4.45 | |
| Equillium (EQ) | 0.1 | $449k | 616k | 0.73 | |
| Astria Therapeutics (ATXS) | 0.1 | $333k | 25k | 13.30 | |
| Allovir (ALVR) | 0.1 | $324k | 82k | 3.94 | |
| Atreca Cl A Com (BCEL) | 0.1 | $300k | 263k | 1.14 | |
| Aeglea Biotherapeutics | 0.1 | $256k | 884k | 0.29 | |
| Science 37 Holdings | 0.1 | $253k | 900k | 0.28 | |
| Kala Pharmaceuticals Com New (KALA) | 0.0 | $181k | 12k | 15.05 | |
| Surrozen | 0.0 | $181k | 300k | 0.60 | |
| Novavax Com New (NVAX) | 0.0 | $147k | 21k | 6.93 | |
| Kronos Bio (KRON) | 0.0 | $114k | 78k | 1.46 | |
| Ngm Biopharmaceuticals | 0.0 | $56k | 14k | 4.08 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $16k | 133k | 0.12 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $10k | 100k | 0.10 |
